Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 7 |
|
|||||
| News | (1) | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| XOMA Corporation | XOMA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 25.64 | 07:53:51 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 25.64 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 7 | - | 13.48 - 27.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 07:39:06 | 7 | $ 26.00 | USD |
XOMA Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 298.09M | 11.63M | - | 4.76M | -40.83M | -3.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
XOMA News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XOMA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 24.25 | 26.79 | 24.24 | 25.44 | 11,917 | 1.39 | 5.73% |
| 1 Month | 23.47 | 27.00 | 23.25 | 25.40 | 14,169 | 2.17 | 9.25% |
| 3 Months | 20.29 | 27.00 | 19.50 | 24.21 | 18,782 | 5.35 | 26.37% |
| 6 Months | 16.65 | 27.00 | 14.27 | 20.19 | 24,604 | 8.99 | 53.99% |
| 1 Year | 18.11 | 27.00 | 13.48 | 18.53 | 30,220 | 7.53 | 41.58% |
| 3 Years | 37.49 | 39.49 | 13.48 | 21.52 | 30,271 | -11.85 | -31.61% |
| 5 Years | 12.18 | 46.32 | 11.58 | 23.19 | 39,416 | 13.46 | 110.51% |
XOMA Description
| XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. |
